Chronic Cough – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Chronic Cough – Drugs In Development, 2024 report and make more profitable business decisions.
Chronic cough is a respiratory disorder, characterized by a persistent cough lasting at least eight weeks or longer. Coughing is a natural defense mechanism, clearing bronchial secretions and eliminating inhaled foreign particles. Chronic cough can result from various causes, including respiratory infections like bronchitis or pneumonia, gastroesophageal reflux disease (GERD), asthma, and postnasal drip. Understanding and addressing the underlying condition is essential in managing chronic cough effectively.
The Chronic Cough drugs in development market research report provide comprehensive information on the therapeutics under development for Chronic Cough, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Cough and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Chronic Cough | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 27 molecules, with 27 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Chronic Cough therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Chronic Cough pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Chronic Cough treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Addex Therapeutics LtdAldeyra Therapeutics Inc
Algernon Pharmaceuticals Inc
Asana BioSciences LLC
Axalbion SA
Chiesi Farmaceutici SpA
Createrna Science and Technology Co Ltd
Exxel Pharma Inc
F. Hoffmann-La Roche Ltd
Future Analgesics
GSK plc
Hangzhou Vitan Pharmaceutical Technology Co Ltd
Integral Molecular Inc
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Merck & Co Inc
NeRRe Therapeutics Ltd
Nippon Chemiphar Co Ltd
Nocion Therapeutics Inc
Regen-Geek (Shenzhen) Medical Technology Co Ltd
Sino Biopharmaceutical Ltd
SiteOne Therapeutics Inc
SolAeroMed Inc
Trevi Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Chronic Cough reports